Case Studies

Featured Case Study

A mid-size specialty pharmaceutical company was interested in licensing promising early-stage compounds in order to add critical mass to its portfolio. To gain clarity about the available options, and which would be a ‘best fit’, they engaged Fuld + Company. As a result of our in-depth primary and secondary research, and resulting recommendations, the company in-licensed two early-stage compounds, one of which they have now successfully brought to market.

Looking for a specific example? Just ask us.

Consumer Packaged Goods + Retail

Financial Services

Healthcare

Life Sciences

Manufacturing + Industrial

Technology + Telecom

Travel + Hospitality

Have a challenge for us? We're here to help.